Page 11 - Eric Althoff News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ng Therapeutics (GRADIENT), with a combined funding commitment of GBP 2.8m (USD 3.6 million) over five years, calls on African researchers to submit robust research proposals on the relevance of African genetic diversity to the treatment of malaria and tuberculosis. 1 Pauline Williams, Senior Vice President Global Health Pharma at GSK said: “At GSK, human genetics is a core pillar of our R&D strategy. Genetic diversity is greater in Africa than in any other continental population resulting in some African patients having varying response to treatments. We are excited to launch Project Afr...

Novartis International AG: Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene Novartis secures development and commercialization rights in North America, Europe, and Japan Accelerates Novartis immuno-oncology combination strategy with multiple potential tislelizumab plus Novartis therapy combinations Tislelizumab already approved for patients with classical Hodgkin's lymphoma and metastatic urothelial carcinoma in China; 15 registration-enabling clinical trials under way in non-small cell lung cancer (NSCLC) and other solid tumors Basel, January 11, 2021 - Novar...

Novartis expands Oncology pipeline with in-licensing of tislelizumab from BeiGene Agreement expands Novartis Oncology portfolio, adding late-stage PD-1 for monotherapy and potential proprietary PD-1 combinations, driving mid- and long-term growth Novartis secures development and commercialization rights in North America, Europe, and Japan Accelerates Novartis immuno-oncology combination strategy with multiple potential tislelizumab plus Novartis therapy combinations Tislelizumab already approved for patients with classical Hodgkin’s lymphoma and metastatic urothelial carcinoma in China; 15 ...

Get the latest industry news first when you subscribe to our daily newsletter. We will never sell or share your information without your consent. See our privacy policy.

HCO News By Eric Althoff CHARLESTON, S.C.—A new 625,000-square-foot women’s and children’s care facility is officially open at the Medical University of South Carolina (MUSC) in Charleston. The Shawn Jenkins Children’s Hospital & Pearl Tourville Women’s Pavilion encompasses 10 stories and has a patient capacity of 250 persons. The tower stands adjacent to an existing four-story medical podium. The MUSC campus specializes in solutions for rare healthcare issues that can be especially sensitive for female patients to discuss openly with their caregivers. These include high-risk pregna...